Healio
›
Hematology/Oncology
›
Neuro-Oncology
›
News
-
Perspective
-
-
HemOnc Today, December 25, 2012
-
The addition of six cycles of procarbazine, lomustine and vincristine chemotherapy to radiotherapy improved OS and PFS among patients with anaplastic...More
»
-
Perspective
-
-
HemOnc Today, December 25, 2012
-
Patients who undergo multiple surgeries to remove glioblastomas may survive longer than those who have just one operation, according to results of a...More
»
-
In the Journals
-
-
HemOnc Today, December 25, 2012
-
Early resection was associated with significantly better survival outcomes among patients with diffuse low-grade gliomas than a treatment regimen that...More
»
-
Meeting News Coverage
-
-
HemOnc Today, November 25, 2012
-
Memantine slows cognitive function decline in patients with brain cancer who received whole-brain radiation therapy, according to results of a phase 3...More
»
-
In the Journals
-
-
HemOnc Today, October 25, 2012
-
The addition of conformal radiation therapy to chemotherapy increased event-free survival in young children with nonmetastatic medulloblastoma, according...More
»
-
Case Challenges
-
-
HemOnc Today, September 10, 2012
Ramya Varadarajan, MD
-
Ramya Varadarajan
A 61-year-old white woman was initially seen by her primary care physician for slow, tentative gait and problems with visual tracking.
...More
»
-
FDA approvals
-
-
HemOnc Today, September 25, 2012
-
The FDA today approved a pediatric dosage form of everolimus to treat subependymal giant cell astrocytoma.
It is the first approved pediatric-specific...More
»
-
In the Journals
-
-
HemOnc Today, September 10, 2012
-
The addition of chemotherapy to radiation improved PFS but did not extend OS in adults with low-grade glioma, according to study results.
A post-hoc...More
»
-
In the Journals
-
-
HemOnc Today, September 25, 2012
-
Elevated serum levels of IgE were associated with a decreased risk for developing glioma or glioblastoma in a recent study.
In the nested case-control...More
»
-
In the Journals
Perspective
-
-
HemOnc Today, September 10, 2012
-
The fusion of FGFR and TACC genes caused a small number of glioblastoma cases, but drugs that target the proteins produced by this synthesis can slow the...More
»